Glycotope
Glycotope總部位于德國的柏林,擁有超過160名員工,Glycotope生物是擁有超過30年的生物制品GMP生產和分析制藥行業的著名的伙伴,Glycotope結構進行藥物開發中的廣泛的客戶的項目中,最引人注目的是生物仿制藥的發展和改進的第二代療法。
Glycotope是最大的糖基化蛋白生產商,是糖基化生物制藥產品包括NBEs,biobetters和biosimilars開發和生產的龍頭企業。在Glycotope大約有120人開發用于生物治療的高產量的細胞生產線,生產工藝,和免疫學和生物化學的方法和生物測定方法,產品符合GMP標準。Glycotope產品線包括改進的抗體和治療性蛋白質。
The Glycotope Group consists of Glycotope GmbH, based in Berlin, Germany and its 100% subsidiary, Glycotope Biotechnology GmbH, based in Heidelberg, Germany. With more than 160 employees, Glycotope represents one of the largest Biotech companies in Germany.
Together, the companies are active in the development of proprietary biopharmaceuticals based on Glycotope′s technologies for a new generation of protein therapeutics.
In our affiliate Glycotope Biotechnology, we perform a wide range of contract research and manufacturing services . While Glycotope Biotechnology, a former part of Orpegen Pharma GmbH, is for now more than 30 years a reknown partner of the pharmaceutical industry for GMP production and analytics of biologics, Glycotope Biotechnology is conducting customer projects in GMP-production and drug development.